Thomas Bengt Eldered

Thomas Bengt Eldered

Net worth: 149 M $ as of 2026-05-30

66 year
Health Technology
Finance
Commercial Services

Profile

Mr. Thomas Bengt Eldered is an Independent Director at Xintela AB, a Chairman at Prokarium Holdings Ltd., a Chairman at Nanologica AB, a Chairman-Supervisory Board at Amarna Therapeutics BV, a Chairman at Recipharm Fontaine SAS, a Chairman at Flerie AB, a Chairman at Recipharm Monts SAS, a Chairman at B&E Participation, Inc., a Chairman at NorthX Biologics Matfors AB, a Chairman at Trimeta LLC, a Chairman of the board at Flerie Invest AB and a Chief Executive Officer at Consort Medical GmbH.
He is on the Board of Directors at Xintela AB, Prokarium Ltd., SymCel AB, Aesica Formulation Development Ltd., Aesica Holdco Ltd., B&E Invest AB, Bohus Biotech AB /Private Group/, Bohus HoldCo AB, Buzzard Pharmaceuticals AB, Chromafora AB, Cordivest AB, Cormorant Pharmaceuticals AB, Flerie Förvaltning AB, Flerie International AB, KAHR Medical Ltd., Pingvinen Penningplacering AB, Recipharm Holdings Ltd., Sixera Pharma AB, T&M Participation AB and Zentricity Holding AB. Mr. Eldered was previously employed as a Chairman by Cobra Biologics Holding AB, a Non-Executive Chairman by Cobra Biologics Ltd., a Vice President by Recip AB, a Factory Manager by Pharmacia AB, a Chairman by B&E Participation AB, a Deputy Director by Empros Pharma AB, and a Co-Managing Director by Recipharm Verwaltungs GmbH.
He also served on the board at Toleranzia AB, Recipharm Ltd., SwedenBIO Service AB, Recipharm AB, Backsell Eldered Holding AB, Flerie Participation AB, Provell Pharmaceuticals LLC, Roar BidCo AB, SwedenBIO Service AB and Zentricity International AB. He received his graduate degree from the University of Linköping.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
FLERIE AB
61.92%
2026-05-19 58,888,047 ( 61.92% ) 149 M $ 2026-05-30

Thomas Bengt Eldered active positions

CompaniesPositionStart
NANOLOGICA AB Chairman 2026-05-20
XINTELA AB Director/Board Member 2021-12-31
FLERIE INVEST AB Founder 2010-12-31
Director/Board Member -
Director/Board Member 2020-02-03
Director/Board Member 2020-02-03
Chairman 2010-03-19
Chairman 2014-04-29
Director/Board Member -
░░░░░░░ ░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ -
░░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ -

Former positions of Thomas Bengt Eldered

CompaniesPositionEnd
░░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Thomas Bengt Eldered's experience

Training of Thomas Bengt Eldered

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

55

1st degree connections

45

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies45

Distribution Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Finance

Health Technology

B&E Invest AB

Health Technology

Technology Services

Health Technology

Health Technology

Finance

Process Industries

Trimeta LLC

B&E Participation, Inc.

Pingvinen Penningplacering AB

Finance

Health Technology

Health Technology

Finance

Commercial Services

Health Services

Finance

Commercial Services

Miscellaneous

Finance

Health Technology

Cordivest AB

Finance

Health Technology

Finance

  1. Stock Market
  2. Insiders
  3. Thomas Bengt Eldered